Rosacea and Ivermectin
Rosacea
About this trial
This is an interventional health services research trial for Rosacea
Eligibility Criteria
Inclusion Criteria:
- Subject is 18 years of age or older.
- Subject has a working knowledge of English.
- Subject with a diagnosis of Rosacea
- Subjects without a known allergy to ivermectin
- Subjects with access to a smart phone
Exclusion Criteria:
- Subjects under 18 years of age.
- Subject does not have a working knowledge of English.
- Subject with a diagnosed skin condition other than rosacea
- Subjects with a known allergy to ivermectin
- Subjects without access to a smart phone
Sites / Locations
- Wake Forest Health Sciences Dermatology
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Experimental
Experimental
Control Group
Digital Interaction Group
GPSkin group
In the control group, all subjects will receive ivermectin equipped with an electronic monitor to measure adherence for daily treatment of rosacea. Subjects will not receive any follow-up intervention from the study team.
The digital interaction group will receive a survey by email each week asking about their use ivermectin generated by Causa Research; in addition to receiving ivermectin equipped with an electronic monitor to measure adherence for daily treatment of rosacea.
The GPSkin group will receive the GPSkin Barrier® to measure their moisture level of their face daily. Subjects will be instructed to use the ivermectin once daily. Subjects also are receiving the ivermectin equipped with an electronic monitor to measure adherence for daily treatment of rosacea.